Chemo naive
Showing 1 - 25 of 2,123
Small Cell Lung Carcinoma Trial in Goyang-si (IP chemo, IP chemo plus simvastatin)
Active, not recruiting
- Small Cell Lung Carcinoma
- IP chemotherapy
- IP chemotherapy plus simvastatin
-
Goyang-si, Gyeonggi-do, Korea, Republic ofNational Cancer Center , Korea
Apr 4, 2022
Prostate Cancer Metastatic Trial in Leiden (Enzalutamide, 18-FDG PET/CT, Whole body MRI)
Completed
- Prostate Cancer Metastatic
- Enzalutamide
- +3 more
-
Leiden, NetherlandsLeiden University Medical Center
Apr 6, 2022
Extensive Stage Small Cell Lung Cancer Trial in Chicago, Indianapolis, Iowa City (Cisplatin, Carboplatin, Etoposide)
Recruiting
- Extensive Stage Small Cell Lung Cancer
- Cisplatin
- +4 more
-
Chicago, Illinois
- +2 more
Jul 1, 2022
Prostatic Tumors, Castration-Resistant Trial (Abiraterone, Apalutamide)
Withdrawn
- Prostatic Neoplasms, Castration-Resistant
- (no location specified)
Nov 15, 2020
Prostatic Tumors, Castration-Resistant Trial in China, Korea, Republic of, Taiwan (Tasquinimod, Placebo)
Terminated
- Prostatic Neoplasms, Castration-Resistant
- Tasquinimod
- Placebo
-
Beijing, Beijing, China
- +35 more
Mar 24, 2021
Prostatic Tumors Trial in Brazil (Abiraterone acetate, Prednisone, Androgen deprivation therapy (ADT))
Completed
- Prostatic Neoplasms
- Abiraterone acetate
- +2 more
-
Porto Alegre, Brazil
- +4 more
Jan 9, 2020
NSCLC Trial in United States (Erlotinib, Hydroxychloroquine)
Unknown status
- Non-small Cell Lung Cancer
-
Stanford, California
- +3 more
Jul 1, 2020
Prostatic Tumors, Immunotherapy, Dendritic Cells Trial in Nijmegen (mDC vaccination, pDC vaccination, mDC and pDC vaccination)
Completed
- Prostatic Neoplasms
- +3 more
- mDC vaccination
- +2 more
-
Nijmegen, Gelderland, NetherlandsRadboud University Nijmegen Medical Centre
Nov 13, 2019
Prostate Cancer Trial in Worldwide (Placebo and prednisone, Abiraterone acetate and prednisone)
Completed
- Prostate Cancer
- Placebo and prednisone
- Abiraterone acetate and prednisone
-
Beijing, China
- +23 more
Jan 16, 2020
Breast Cancer Trial in Taiwan (Epirubicin+Cyclophosphamide, liposomal-doxorubicin+Cyclophosphamide)
Active, not recruiting
- Breast Cancer
-
Changhua, Taiwan
- +8 more
Nov 22, 2021
Metastatic Disease Trial in Mainz (BIBW 2992)
Terminated
- Metastatic Disease
- BIBW 2992
-
Mainz, GermanyI. Medizinische Klinik und Poliklinik der Universitätsmedizin
Aug 26, 2019
NSCLC Trial in Rochester (Tetrathiomolybdate)
Completed
- Non-Small Cell Lung Cancer
-
Rochester, New YorkUniversity of Rochester
Jul 17, 2019
Lung Cancer, Esophageal Cancer Trial in Philadelphia (Pulsed Low Dose Radiation, Carboplatin, Paclitaxel)
Recruiting
- Lung Cancer
- Esophageal Cancer
- Pulsed Low Dose Radiation
- +2 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Dec 2, 2022
Malignant Ascites Trial in Taichung (Nivolumab, Pembrolizumab)
Enrolling by invitation
- Malignant Ascites
-
Taichung, Please Select, TaiwanChina Medical University Hospital
Feb 16, 2023
Biliary Tract Cancer Trial in Montréal (Tumour and germline molecular profiling)
Recruiting
- Biliary Tract Cancer
- Tumour and germline molecular profiling
-
Montréal, Quebec, CanadaMcGill University Health Centre
Nov 2, 2022
Esophageal Cancer Trial in Daegu (chemoradiotherapy)
Recruiting
- Esophageal Cancer
- chemoradiotherapy
-
Daegu, Korea, Republic ofKyungpook National University Medical Canter
Aug 8, 2021
Breast Cancer, Triple Negative Breast Cancer, Dietary Exposure Trial (Control diet (ARM A) or Fasting-Like Approach (FLA, ARM
Not yet recruiting
- Breast Cancer
- +3 more
- Control diet (ARM A) or Fasting-Like Approach (FLA, ARM B)
- (no location specified)
Feb 28, 2023
Squamous Cell Carcinoma of Head and Neck Trial in Shanghai (Camrelizumab+cetuximab+chemo)
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
-
Shanghai, ChinaFudan University
Jan 4, 2023
Diffuse Large B-cell Lymphoma (DLBCL) Trial in Lanzhou (Zanubrutinib)
Not yet recruiting
- Diffuse Large B-cell Lymphoma (DLBCL)
-
Lanzhou, Gansu, ChinaThe First Hospital of Lanzhou University
Oct 23, 2022
Novel MRI Techniques for Pancreatic Cancer
Withdrawn
- Pancreatic Ductal Adenocarcinoma
- MRI
- (no location specified)
Jul 19, 2022
Immunophenotyping of Metastases From Colorectal Cancer
Completed
- Metastatic Colorectal Cancer
-
Padova, ItalyIstituto Oncologico Veneto IRCCS
Nov 19, 2020
NSCLC (NSCLC) Trial in New York (Pembrolizumab)
Not yet recruiting
- Non-Small Cell Lung Cancer (NSCLC)
-
New York, New YorkMount Sinai Hospital
Jan 23, 2023
Colorectal Cancer, Liver Metastases, Liver Metastasis Colon Cancer Trial in Amsterdam (Neoadjuvant systemic therapy (CAPOX+/-B
Recruiting
- Colorectal Cancer
- +5 more
- Neoadjuvant systemic therapy (CAPOX+/-B FOLFOX+/-B FOLFIRI+/-B)
- Repeat local treatment
-
Amsterdam, NetherlandsAmsterdam UMC
May 5, 2023
Wnt, Notch and Hedgehog Activity in Chemo-Naive Tumors Collected
Terminated
- Esophageal Cancer
- Tumor Biopsy via Ultrasound Endoscopy
-
Miami, FloridaUniversity of Miami
Jan 11, 2019